Tony is an Honorary Consultant Physician (Addenbrooke’s Hospital, CUHFT) and a University Lecturer in Clinical Biochemistry. He is based within the Wellcome Trust-MRC Institute of Metabolic Science (IMS), a purpose-built centre on the Cambridge Biomedical Campus dedicated to research, education, prevention and clinical care in the areas of obesity, diabetes and related diseases.
Studies the molecular mechanisms controlling food intake and energy expenditure
Tony is an Honorary Consultant Physician (Addenbrooke’s Hospital, CUHFT) and a University Lecturer in Clinical Biochemistry. He is based within the Wellcome Trust-MRC Institute of Metabolic Science (IMS), a purpose-built centre on the Cambridge Biomedical Campus dedicated to research, education, prevention and clinical care in the areas of obesity, diabetes and related diseases.
He qualified in Medicine at King’s College Hospital, London and undertook postgraduate training in London and Cambridge. He is a Principal Investigator at the University of Cambridge Metabolic Research Laboratories. With O’Rahilly and Yeo, he is a programme lead within the MRC Metabolic Diseases Unit. This research programme aims to understand the biological processes controlling what we eat and how we store and use energy. These pathways are disturbed in obesity and related metabolic conditions such as Type 2 diabetes, and this knowledge will ultimately lead to development of new treatments for these disorders. Dr Coll has a particular expertise in using murine models to address these issues, in particular how signals from peripheral organs are integrated within the brain to change appetitive behaviour. With Connell, Jodrell and Janowitz he is using the tools and methodologies that have proven to be successful in understanding obesity to gain insights into the endocrine and behavioural disturbances that contribute to disrupted appetitive behaviour in cancer cachexia.